29527-27-3 Usage
General Description
4-triazole-3-thiol,5-(p-chlorophenyl)-4-methyl-4h-2 is a chemical compound that belongs to the class of triazole derivatives. It is a heterocyclic compound that contains a five-membered ring with three nitrogen atoms and two carbon atoms. The molecule also includes a thiol group and a p-chlorophenyl group, as well as a methyl group. 4-triazole-3-thiol,5-(p-chlorophenyl)-4-methyl-4h-2 has potential applications in the fields of pharmaceuticals and agrochemicals due to its diverse biological activities, including antifungal and antibacterial properties. It also possesses potential as a building block in organic synthesis for the development of new chemical entities with specific properties and activities. Further research on the compound may lead to the discovery of novel applications and potential uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 29527-27-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,5,2 and 7 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 29527-27:
(7*2)+(6*9)+(5*5)+(4*2)+(3*7)+(2*2)+(1*7)=133
133 % 10 = 3
So 29527-27-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H8ClN3S/c1-13-8(11-12-9(13)14)6-2-4-7(10)5-3-6/h2-5H,1H3,(H,12,14)
29527-27-3Relevant articles and documents
Synthesis, antifungal activity, 3d-qsar, and molecular docking study of novel menthol-derived 1,2,4-triazole-thioether compounds
Duan, Wen-Gui,Huang, Mei,Li, Bao-Yu,Lin, Gui-Shan
, (2021/11/30)
A series of novel menthol derivatives containing 1,2,4-triazole-thioether moiety were designed, synthesized, characterized structurally, and evaluated biologically to explore more potent natural product-based antifungal agents. The bioassay results reveal
Design, synthesis and antibacterial evaluation of 1-[(1R,2S)-2-Fluorocyclopropyl] Ciprofloxacin-(4-Methyl-3-Aryl)-1,2,4-Triazole-5(4H)-Thione Hybrids
Geng, Yun-He,Wei, Zeng-Quan,Xu, Zhi,Na, Lu-Xin,Zhang, Shu,Guo, Hui-Yuan,Liu, Ming-Liang,Feng, Lian-Shun,You, Xue-Fu
, p. 101 - 107 (2019/08/01)
Fourteen novel 1-[(1R,2S)-2-Fluorocyclopropyl]ciprofloxac in-(4-methyl-3-aryl)-1,2,4-triazole-5(4H)-thione hybrids 6a-n were designed, synthesized and assessed for their in vitro antibacterial activities against representative Gram-positive and Gram-negat
NEW COMPOUNDS
-
Page 142, (2010/02/06)
The present invention relates to new compounds of formula I, (I) a process for their preparation and new intermediates prepared therein, pharmaceutical formulations containing said compounds and to the use of said compounds in therapy.